Compare BEEM & HIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BEEM | HIND |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.4M | 28.0M |
| IPO Year | N/A | 2016 |
| Metric | BEEM | HIND |
|---|---|---|
| Price | $1.69 | $3.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 208.3K | N/A |
| Earning Date | 11-14-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $27,668,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $45.61 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.33 | N/A |
| 52 Week High | $4.04 | N/A |
| Indicator | BEEM | HIND |
|---|---|---|
| Relative Strength Index (RSI) | 45.65 | 34.02 |
| Support Level | $1.62 | $3.11 |
| Resistance Level | $1.72 | $3.69 |
| Average True Range (ATR) | 0.10 | 0.25 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 70.49 | 22.86 |
Beam Global produces sustainable technology for electric vehicle (EV) charging, outdoor media, and energy security, without the construction, disruption, and costs of grid-tied solutions. Its products are founded upon its patented EV ARC and Solar Treelines and include BeamTrak patented solar tracking, and ARC Technology energy storage, along with EV charging, outdoor media, and disaster preparedness packages. From start to finish, the company develops, patents, designs, engineers, and manufactures renewably energized products that help the environment, empower communities, and keep people moving.
Vyome Holdings Inc is a reseach and development company. The Company operates in two segments, biotechnology and pharmaceutical products. The biotechnology segment comprises of operations around VT-1953, VT-1908, and VB-1953 programs that are in development, and the pharmaceutical segment comprises of antifungal products manufacturing and distribution.